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Abstract Senescence evolved because selection
pressure declines with age. However, to explain
senescence it does not suffice to demonstrate that
selection pressure declines. It is also necessary to
postulate biological mechanisms that lead to a dete-
riorated state of the organism at high ages, but not
before. This has lead to the invocation of ‘age-
specific’ genes or processes, a concept which is prone
to be interpreted too freely. Events do not happen after
a certain amount of time has passed. They need
initiation, which means that senescence is required to
be a continuous process. As a result, a change at a
particular age cannot arise in isolation from changes at
other ages, in particular not in isolation from changes
at the ages nearby. These mechanistic constraints are
not without consequence for the patterns of mortality
and fecundity that can evolve. I conclude that from
purely logical considerations, senescence is charac-
terized as continuous rather than age-specific deteri-
oration. These considerations guide (theoretical)
research in the direction of investigating how
continuous somatic change arises, rather than focusing
at age-specific events.
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Introduction: the evolution of senescence
and the meaning of age-specificity
The higher the age of an organism, the greater the
organism’s contribution to fitness that cannot be
affected by any event happening at that age, because
that contribution lies in the past. As a result, the state
of an organism at high age is under less stringent
selection than the state of the organism at low age,
which promotes the evolution of ‘senescence’, the
deterioration of the state of an organism over ages,
which negatively affects ‘vital rates’ mortality and
fecundity (Medawar 1952; Williams 1957; Hamilton
1966).
To explain aging, it does not suffice to conclude that
selection pressure declines over ages. It is also
necessary to define the processes that are hypothesized
to lead to a deteriorated state at high ages, but not
before. This has lead to the invocation of ‘age-specific
genes’, thus giving a genetic basis to the deteriorated
state (Medawar 1952; Williams 1957; Hamilton 1966).
However, this still allows for different interpretations.
If ‘age-specific’ is to mean ‘a gene that is expressed at
some age but not before (or after)’, there is a logical
M. Wensink (&)
Max Planck Research Group: Modeling the Evolution of
Aging, Max Planck Institute for Demographic Research,
Konrad Zuse Strasse 1, 18057 Rostock, Germany
e-mail: wensink@demogr.mpg.de
M. Wensink
Leyden Academy on Vitality and Ageing, Poortgebouw





problem if such genes are taken as the source of
senescence. As Kirkwood (1977) observed: ‘‘the time
of action of a gene during adulthood is determined not
by chronological time but by its biochemical environ-
ment’’, so that the ‘‘time-keeping process’’ or ‘somatic
change’, a change in the biochemical environment that
triggers a change in gene action, should be explained
before age-specific alterations in gene action can be
considered. At this point it is necessary to specify what
is meant by ‘gene action’. If the expression of a gene
would for example lead to the accumulation of damage
(see below), the rate of accumulation of damage is the
gene action. The result of this action is that over time
there is an increase (change) in the amount of damage
that has been accumulated, while the gene action has
remained unchanged. A change in the gene action itself
would mean that the expression of the gene leads to a
different rate of accumulation, which can only occur if
some somatic change occurs first. Thus, there can be
change of the state of the organism without a change in
gene action, but there can be no change in gene action
without a somatic change that initiates this change in
gene action (Kirkwood and Melov 2011). Any change
in gene action is state-specific rather than age-specific.
This is a logical issue, unrelated to empirical evidence:
events need initiation. They do not just happen because
a sufficient amount of time has passed. Consequently,
the process that causes senescence is necessarily
continuous.
From the logical necessity that senescence is a
continuous process there arises a natural alternative to
the definition of age-specificity above. An ‘age-
specific process’ could be defined as a process that
leads to a certain state of an organism at a specific age,
while actually taking place at all preceding (and
subsequent) ages. The logical problem outlined above
is then avoided, although it does not seem entirely
correct to call such processes age-specific. From now
on I refer to such processes as ‘continuous’. The
question then arises whether it is possible that a
continuous process has a certain effect on vital rates at
some isolated age, but no effect before or after that age.
To sum up, there exist two interpretations of age-
specificity: One at high risk of circularity, because in
order to have age-specificity at all, it requires the
existence of the very change it set out to explain, and
one that avoids this risk, but for which ‘age-specific-
ity’ may not be the correct word. While some think
about senescence in terms of the latter interpretation,
others have tried to formulate theories of genes,
causative for senescence, that do switch expression
with age, or whose expression does lead to a different
outcome at different ages, while avoiding the logical
problem that Kirkwood pointed out. In this paper I
show that these ‘reparations’ failed, and that if we wish
to include genes that change their action or expression
at some age(s) in an evolutionary theory of senes-
cence, such state-specific genes play a role that is
qualitatively different from the role that they are
currently believed to play. Furthermore I discuss the
difficulties of the idea that a continuous process has a
certain effect on vital rates at some isolated age, but no
effect before (or after) that age. I conclude that
senescence should be considered as continuous
somatic change, with continuous change in vital rates.
Age-specific deleterious effects derived
from state-specific genes
Proposals to retain a place for ‘age-specific’, more
correctly ‘state-specific’, genes in the evolutionary
theory of senescence, appeal to (hypothetical) pro-
cesses that have two characteristics. First, such
processes are assumed to evolve independently of the
presence of state-specific genes, so that potentially
deleterious genes could measure the age of the
organism from those processes. Second, such pro-
cesses are postulated to have no direct effect on vital
rates, so that the deleterious effect is mediated through
state-specific genes, with the result that the deleterious
effect takes place at some specific age. This idea is
perhaps best articulated by (Dawkins 2006). He
discussed a ‘‘substance S’’ (S for senescence) which
is innocuous in itself, but which accumulates in cells,
and which triggers a change of gene action when its
concentration reaches a certain threshold. Thus, sub-
stance S is seen as an independent time-keeper. A
similar argument from the perspective of telomere
length is sometimes raised in informal discussions. A
telomere is a protective DNA sequence at the end of the
chromosome, the length of which is a decreasing
function of age in humans (Blackburn 1991). The idea
is that genes could sense the length of telomeres, and so
could have age-specific effects. As discussed below,
the presumed independence from state-specific genes
of the somatic change cannot possibly be upheld, while
the presumed innocuousness is doubtful at best.
100 Biogerontology (2013) 14:99–105
123
There is no independent time-keeping mechanism
Even if substance S has no direct effect on vital rates,
the triggering of deleterious age-specific genes is a far
from innocuous activity. Accordingly, substance S is
subject to natural selection, which means that the pace
of accumulation of substance S can be manipulated by
natural selection to postpone or forestall the action of
potentially deleterious state-specific genes (Fig. 1).
Deterioration of vital rates is caused by both substance
S and the state-specific genes: Only if both factors are
present does deterioration occur. The greater the
number, severity, or sensitivity to somatic change of
potentially deleterious state-specific genes (‘state-
specific load’), the greater the deterioration that results
if the somatic change triggers those state-specific
genes, and the stronger natural selection will act
against this somatic change. Hence, the idea of a
‘‘substance S’’ as a somatic change that functions as a
sort of clock, independently of the presence of state-
specific genes, cannot be entertained. The same goes
for telomere length: Whether contributing directly to
the process of senescence or not (see below), an
increase in state-specific load will increase selection
on the activity of telomerase [an enzyme that reverses
telomere shortening (Blackburn 1991)]. This view-
point is quite different from the idea that state-specific
genes can be superimposed on some existing change,
which itself evolves independently.
That somatic change does not evolve independently
is demonstrated by the following. Consider again that
because substance S triggers genes to exert a detri-
mental effect, natural selection acts on the rate at
which substance S is produced and on the rate at which
it is cleared. In fact, the force of selection on substance
S equals the force of selection on all individual state-
specific genes that are triggered by substance S added
up. Clearance of substance S could come at a cost,
such as in cases in which the resources (energy,
metabolites) that are used to clear substance S could
otherwise have been used for reproduction. Alterna-
tively, metabolism that involves a lower rate of
production of substance S could require more
resources.
Now consider what happens if only one state-
specific gene is present, which gives a slight increase
in mortality when activated at some threshold con-
centration of substance S. If there is some cost of
Fig. 1 The interaction of somatic change and state-specific
genes. Organisms are depicted as boxes, at different instants in
time (arrow). State-specific genes (depicted as 0’s) can have
detrimental action (when they become daggers), depending on
the somatic change (grey tint of the background). The somatic
change is assumed to have no noxious effect other than
activating detrimental state-specific gene action. The rate of
senescence is then the rate at which gene action becomes
detrimental. The relevance of the somatic change to the theory
becomes abundantly clear when comparing organism a with
organism b. Organism b has a higher state-specific load (higher
number of 0’s), but because of a slower somatic change, it has a
lower rate of senescence
Biogerontology (2013) 14:99–105 101
123
clearing substance S, this could easily outweigh the
cost of the slight incrzease in mortality at some age.
Now increase the state-specific load. First, the rate of
senescence will increase due to the higher state-
specific load. However, at some point the mortality
costs could outweigh the benefits of an alternative
investment of resources. Instead of removing those
state-specific genes with too detrimental an effect,
natural selection may lead to clearance of substance S.
As a result, the detrimental effect of all state-specific
genes sensitive to substance S is forestalled, and the
rate of senescence decreased. Of course, other somatic
changes may still make the organism deteriorate. Also,
if selection pressure on the potential action of state-
specific genes is low enough, benefits of preventing
this action may never outweigh cost. Nevertheless, the
possibility that an increase in the state-specific load
leads to a lower rate of senescence is notable.
Although state-specific genes certainly act as a
reinforcing factor given a certain pace of the somatic
change, following the reasoning above a higher state-
specific load does not necessarily lead to a(n) (propor-
tional) increase in the rate of senescence. This effect
emerges through the evolution of a slower somatic
change in response to an increase in state-specific
load.
Are there innocuous time-keeping mechanisms?
Above it was demonstrated that the ‘time-keeping’
mechanism, or somatic change, does not evolve
independently of the state-specific load. In addition,
we might ask whether the second putative attribute of
somatic change, the lack of a direct effect on the
organism’s vitality, is realistic. In the case of sub-
stance S, I suggest that it is unclear how an accumu-
lating substance would not interfere with (cellular)
signaling or the structural integrity of the organism.
An effect may be expected even if some substance is
chemically inactive, if only through the occupation of
space, or through the addition of non-functional
weight. If the somatic change is damage, as in the
disposable soma theory, it is difficult to conceptualize
how the damage would be free of any effect on vital
rates. Indeed, central to the disposable soma theory is
the idea that it is (the accumulation of) damage that
leads to deterioration (Kirkwood 1977; Kirkwood and
Holliday 1979; Kirkwood and Rose 1991). Similarly,
changes that telomeres undergo over ages, such as loss
of methylation, have been demonstrated to have direct
effects on the vitality of the organism, while the
shortening of telomeres with cell division is not
universal (Macieira-Coelho 2011). I am not aware of
any demonstration of a substance or other change that
has no direct effect on vital rates, but that informs
genes about the age of the organism, since Kirkwood
(1977) objected along similar lines.
In conclusion there are two objections to the
concept that senescence is a result of age-specific
deleterious effects derived from state-specific genes.
First, there is no independent time-keeping mecha-
nism, which means that potentially deleterious state-
specific genes cannot be thought of as independent
from the somatic change on which their activation
relies. Second, because it is doubtful whether some
somatic change can be without any effect on vital
rates, an underlying continuous somatic change is
expected to lead to a gradual deterioration of vital
rates, rather than to age-specific deterioration.
Age-specific deleterious effects derived directly
from continuous change
All the difficulties discussed above are avoided if the
deterioration that characterizes senescence is viewed
as the direct result of some continuous change, without
mediation of some state-specific gene. With a contin-
uous process directly causing senescence, the potential
logical problem to explain what initiates deterioration
does not exist. The question now arises to what extent
it is possible that the deleterious effect of a continuous
process takes place at some age, but not before or after.
This seems to be even less likely than if the deleterious
effect is mediated through a state-specific gene, in
which case the somatic change is not directly harmful.
As the somatic change takes place, it will likely give
rise to some deterioration. There are, however, two
reasons to expect that the bulk of the deleterious effect
may be manifest only late. First, somatic change may
be expected to be cumulative, for instance in case of
cumulative damage, so that it may be expected that the
higher the age, the greater the effect. Second, the
amount of accumulated damage may translate into
vital rates in a non-linear fashion. This could be the
result of mechanisms that buffer, adapt, or remodel,
leading to only a negligible decline of functioning
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initially (see e.g. Rattan 2006). It could also be that a
decline in functioning is translated into change in vital
rates in a non-linear fashion, for instance exponen-
tially. Consequently the continuum of change has the
highest effect at high ages, so that the somatic change
leads to a deterioration of vital rates at high ages, but
not so much before, as is required to explain
senescence.
The concept of gradual somatic change rather than
age-specificity is corroborated by the evidence on the
mechanistic, the physiological and the demographic
level. At the molecular level, there is for instance a
gradual increase in molecular damage and heteroge-
neity (Rattan 2006, 2010), gradual malfunctioning of
the cellular control systems (Hubbard et al. 2012), and
decline of the integrity of mitochondrial constituents
(Passarino et al. 2010). At the physiological level,
senescence is characterized by gradual loss of func-
tion, for instance in the case of grip strength (Kallman
et al. 1990; Andersen-Ranberg et al. 2009). At the
demographic level, there is a gradual decline in
fertility and a gradual increase in mortality. This is
found in humans (Vaupel 2010) and in wild animals,
where senescence occurs in many natural populations,
and in a gradual fashion, i.e. senescence does not
suddenly happen at some age (Finch 1990; Nussey
et al. 2006; Jones et al. 2008; Jones et al. unpublished).
Discussion
It is possible (but theoretically superfluous) to postu-
late state-specific genes on top of, but not instead of,
continuous somatic change. As discussed above, the
evolution of somatic change is then not independent of
the state-specific genes, and some direct effect of
somatic change on vital rates may be expected. If
senescence is caused by an accumulation of damage
that leads to a changing state of the organism, as in the
disposable soma theory, this changing state could
trigger potentially deleterious genes in turn. Kirkwood
(1977); Kirkwood and Holliday (1979) and later
Zwaan (1999) discussed this possibility, and con-
cluded that if state-specific genes are triggered by
somatic change, the process of senescence is rein-
forced. Certainly, cumulative damage may trigger
state-specific genes. However, just as when state-
specific genes are super-imposed on a substance S, an
increase in the state-specific load does not necessarily
increase the rate of senescence. If the accumulation of
some type of damage could be prevented at low cost,
an increase in the state-specific load to this damage
may lead to slower accumulation of damage, with a
lower rate of senescence as a result.
The conclusion that senescence is a continuous
process, best characterized by decreasing deterioration
over all ages, pertains to two contrasting ideas about
the evolutionary theory of senescence that exist in
parallel. First, there is the idea that senescence does
not occur before some age at which selection pressure
is virtually zero, called ‘essential lifespan’ (Rattan
2000) or ‘warranty period’ (Carnes 2011). Second,
there seems to be the idea that mortality is approxi-
mately inversely related to selection pressure,
although quantitative statements are not made (e.g.
Partridge and Barton 1993; Charlesworth 1994).
Neither of these takes seem entirely satisfactory in
the context of the evolution of senescence, given the
considerations in this paper. As for the concept of an
‘essential lifespan’ or a ‘warranty period’, selection
pressure tends to decline in a gradual fashion. If we
consider an iteroparous organism that does not
senesce, the standard default situation in reasoning
about the evolution of senescence, selection pressure
is an exponentially declining function of age. As a
result it is hard to pin down a specific lifespan that
could be called ‘essential’. Only after the evolution of
senescence could such an age be approximated. As
selection pressure declines gradually, it would be more
natural to expect senescence to be a similar gradual
process, happening at all ages with deterioration
approximately inverse to selection pressure, i.e. the
other concept mentioned above. However, this con-
cept is unsatisfactory because only the gradual decline
of selection pressure is considered, but not the fact that
the state of the organism at one age is tied to the state
of the organism at preceding and subsequent ages,
which takes away degrees of freedom from the
patterns of senescence that can evolve. As Kirkwood
and Shanley (2010) pointed out, this means that the
age-pattern of selection pressure has only limited
informative power, since a pattern approximately
inverse to selection pressure may not be mechanisti-
cally allowed. Thus, there are two different gradual
processes that interact to lead to the evolution of
senescence. A straightforward way of modelling that
follows from these considerations would be to trade
the initial (meaning ‘at maturity’) value of the vital
Biogerontology (2013) 14:99–105 103
123
rates for their rate of change. An initial good
performance (low mortality and/or high fecundity)
then leads to faster decline (see for instance Kirkwood
and Rose (1991), appendix).
To summarize, there are two requirements that the
mechanisms that are believed to give rise to senes-
cence should fulfill. First, the bulk of the deterioration
should happen late rather than early. In parallel, such
processes are required to be continuous rather than
age-specific, for otherwise no proper account of
causality is given. Processes that fulfill these condi-
tions, conditions that are derived purely on logical
grounds, are prone to be cumulative and to translate
into vital rates in a non-linear fashion, so that high ages
are affected much more than early ages. This does not
mean that early ages are not affected at all, which may
be hard to achieve from a mechanistic perspective (see
above). Senescence being a gradual process, theoret-
ical research should focus on what causes the contin-
uous somatic change (see e.g. Kozlowski 1999;
Cichon and Kozlowski 2000; Baudisch 2008; Wen-
sink et al. 2012).
Conclusions
1. The process that underlies senescence is one that
is continuous.
2. Whether this continuous process has effects other
than those mediated through state-specific genes
is irrelevant to the question whether it is subject to
natural selection or not. It is, and this selection
should be included in theories and models.
3. State-specific genes are part of the mechanism by
which somatic change affects vital rates, and they
may lead to a higher rate of senescence, but also to
a lower rate of senescence because of the evolu-
tion of slower somatic change in response. An
increase in the rate of somatic change, on the other
hand, always leads to an increase in the rate of
senescence.
4. Cumulative somatic change will have some
effects at early ages, although these may be
negligible.
5. The main evolutionary question about senescence
is what drives continuous somatic change, rather
than what age-specific genes exist.
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